Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study.

Content Provider	Europe PMC
Author	Kamrul-Hasan, A.B.M. Alam, Muhammad Shah Kabir, Md. Ahamedul Chowdhury, Sumon Rahman Hannan, Muhammad Abdul Chowdhury, Emran Ur Rashid Ahsan, Md. Mainul Mohana, Choman Abdullah Iftekhar, Mohammad Hasan Hasan, Mohammad Jahid Talukder, Samir Kumar
Copyright Year	2023
Abstract	AimsTo risk-stratify patients with type 2 diabetes mellitus (T2DM) according to the IDF-DAR 2021 guidelines and observe their responsiveness to risk-category-based recommendations and fasting experience.MethodsThis prospective study, conducted in the peri-Ramadan period of 2022, evaluated adults with T2DM and categorized them using the IDF-DAR 2021 risk stratification tool. Recommendations for fasting according to the risk categories were made, their intention to fast was recorded, and follow-up data were collected within one month of the end of Ramadan.ResultsAmong 1328 participants (age 51.1 ± 11.9 years, female 61.1 %), only 29.6 % had pre-Ramadan HbA1c < 7.5 %. According to the IDF-DAR risk category, the frequencies of participants in the low-risk (should be able to fast), moderate-risk (not to fast), and high-risk (should not fast) groups were 44.2 %, 45.7 %, and 10.1 %, respectively. Most (95.5 %) intended to fast, and 71 % fasted the full 30 days of Ramadan. The overall frequencies of hypoglycemia (3.5 %) and hyperglycemia (2.0 %) were low. Hypoglycemia and hyperglycemia risks were 3.74-fold and 3.86-fold higher in the high-risk group than in the low-risk group.ConclusionThe new IDF-DAR risk scoring system seems conservative in the risk categorization of T2DM patients in terms of fasting complications.
Related Links	https://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC9969239&blobtype=pdf
Journal	Journal of Clinical & Translational Endocrinology [J Clin Transl Endocrinol]
Volume Number	31
DOI	10.1016/j.jcte.2023.100315
PubMed Central reference number	PMC9969239
PubMed reference number	36861141
e-ISSN	22146237
Language	English
Publisher	Elsevier
Publisher Date	2023-02-16
Access Restriction	Open
Rights License	This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). © 2023 The Author(s)
Subject Keyword	IDF-DAR risk calculator T2DM Ramadan fasting Fasting complications Hypoglycemia
Content Type	Text
Resource Type	Article
Subject	Endocrinology Endocrinology, Diabetes and Metabolism